I must admit I am a bit concerned they only stated that end points had been met- a reduction on relevant assessment measures, but no results or indication of whether it performed better than a placebo, as opposed to existing best treatment... many placebo's have up to 30% improvement, so I hope it will be significant, which should be evident already.
Ann: End-of-Treatment Milestone Met in Phase 2 PTSD Trial, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
